Market Overview

Reliv International Reports First-Quarter Financial Results for 2019


CHESTERFIELD, Mo., May 10, 2019 (GLOBE NEWSWIRE) -- Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2019.

First-Quarter Results

Reliv reported net sales of $9.5 million for the first quarter of 2019 compared with net sales of $10.0 million in the first quarter of 2018. Net sales in the United States decreased to $7.1 million in the first quarter of 2019, which represented a 7.3% decline in net sales when compared to the prior-year quarter.  Net sales in Reliv's foreign markets increased 1.9% in the first quarter of 2019 compared with the prior-year first quarter.  Increases in net sales in Asia and Mexico were 57.9% and 27.1%, respectively, in the first quarter of 2019, offset by a decrease in net sales in Europe of 19.4%, along with decreases in other regions. 

Reliv reported net income for the first quarter of 2019 of $624,000 (earnings per diluted share of $0.36) compared to a net loss of $238,000 (loss per diluted share of $0.13) in the first quarter of 2018.  The income from operations for the first quarter of 2019 was $199,000 compared to a loss from operations of $224,000 in the same period in 2018.  Results from operations were primarily impacted by a reduction of selling, general and administrative expenses ("SGA"), partially offset by the decline in net sales and gross margin.  SGA expenses decreased to $3.7 million in the first quarter of 2019 from $4.5 million in the first quarter of 2018.  Additionally, other income in the first quarter of 2019 includes a gain of $435,000 from the sale of manufacturing equipment as part of an asset sale with Nutracom, LLC.

On January 1, 2019, Reliv entered into a purchase agreement with Nutracom, LLC that included the sale of its manufacturing equipment and most of its raw material inventory.  In addition to the purchase agreement, Reliv entered into several other agreements with Nutracom, including a product supply agreement and a lease agreement, under which Nutracom will lease the manufacturing and warehouse space of Reliv's headquarters building, along with a portion of the office space. 

"We believe 2019 represents a year of innovation and growth," commented Ryan A. Montgomery, Chief Executive Officer.  "With our agreement with Nutracom and the Hastings family to operate the production facility, Reliv continues to enjoy the same high level of service, quality control, flexibility, and efficiencies prior to the transition, but it allows us to focus solely on our core business—providing an outstanding line of nutritional supplements through our independent distributors.  We look forward to a number of transformational changes to Reliv this year, including a new product line on the horizon."

In other developments in the United States, Reliv successfully rolled out a new feature to its compensation plan this March to pay wholesale profit to distributors on a weekly basis. "This feature rewards our best and most productive distributors a meaningful portion of their earnings almost immediately.  This provides them with the rewards of the compensation plan to use as they wish and the ability to reinvest in their business," said Montgomery.

In international operations, sales and distributor activity in the Philippines and Mexico continue to accelerate.  "Our growth in these markets is driven by outstanding growth in our distributor and preferred customer base," noted Montgomery.  Net sales in the Philippines grew by 68.8% in local currency in the first quarter of 2019, compared to the prior-year quarter, as the active distributor and preferred customer count across all of the Asia markets increased by 66%.  "We are very pleased by the pace of growth in the Philippines and are looking to replicate the strategies used there in our other Asia-Pacific markets," said Montgomery.  "Clearly, it's an exciting time for both of our Philippines and Mexico markets."

Reliv had cash and cash equivalents of $2.4 million as of March 31, 2019, compared to $2.0 million as of December 31, 2018.  Net cash used in operating activities was $127,000 in the first quarter of 2019.

As of March 31, 2019, Reliv had 32,300 distributors and preferred customers – an increase of 0.6 percent from March 31, 2018 – of which 2,740 are Master Affiliate level and above.  The number of Master Affiliates decreased by 12.7 percent compared to the year-ago total.  Master Affiliate is the level at which distributors are eligible to earn generation royalties.

About Reliv International, Inc.

Reliv International, based in Chesterfield, MO, produces nutritional supplements that promote optimal nutrition. Reliv supplements address core nutrition and targeted solutions. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, a soy peptide that works at the epigenetic level to promote optimal health. The company sells its products through an international network marketing system of independent distributors in 14 countries. Learn more about Reliv at, or on FacebookTwitter or Instagram.

Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv's business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company's web site,


Reliv International, Inc. and Subsidiaries      
Condensed Consolidated Balance Sheets      
    March 31     December 31    
    2019     2018    
    (Unaudited)     (Audited)    
Current Assets:      
Cash and cash equivalents   $2,381,087     $1,989,974    
Accounts receivable, less allowances of $5,000 in 2019 and 2018   245,999     400,759    
Notes & accounts receivables & deposits - related parties   1,269,527     151,222    
Inventories   2,263,669     2,954,947    
Assets held for sale   -     2,124,939    
Other current assets   714,543     464,165    
Total current assets   6,874,825     8,086,006    
Notes & accounts receivables - related parties   2,897,249     1,282,072    
Other assets   3,179,709     2,287,237    
Net property, plant and equipment   4,649,489     4,698,550    
Total Assets   $17,601,272     $16,353,865    
Liabilities and Stockholders' Equity      
Accounts payable, accruals & other current liabilities   $4,327,609     $3,915,390    
Revolving line of credit   500,000     -    
Other noncurrent liabilities   642,501     445,611    
Stockholders' equity   12,131,162     11,992,864    
Total Liabilities and Stockholders' Equity   $17,601,272     $16,353,865    
Consolidated Statements of Operations      
    Three months ended March 31    
    2019     2018    
    (Unaudited)     (Unaudited)    
Product sales   $8,810,997     $9,391,381    
Freight income   519,941     611,858    
Other revenue   158,566     -    
Net Sales   9,489,504     10,003,239    
Costs and expenses:      
Cost of goods sold   2,433,732     2,349,742    
Distributor royalties and commissions   3,117,572  
View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at